================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
---------------------
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): JANUARY 12, 2000
SYNBIOTICS CORPORATION
(Exact name of registrant as specified in its charter)
COMMISSION FILE NUMBER 0-11303
CALIFORNIA 95-3737816
(State or other jurisdiction (I.R.S. Employer
of incorporation) Identification No.)
11011 VIA FRONTERA
SAN DIEGO, CALIFORNIA 92127
(Address of principal executive offices) (Zip Code)
REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE: (858) 451-3771
================================================================================
ITEM 5. OTHER EVENTS
------------
On January 13, 2000 we announced that we acquired W3Commerce LLC, a privately-
held Internet services provider based in San Diego. We paid $2,183,000 for
W3Commerce, and the consideration was in the form of a 5 year note which bears
interest at 6.21% and is convertible into 1,000,000 shares of our common stock
beginning January 12, 2002. The former shareholders of W3Commerce may receive
up to an additional 800,000 shares of our common stock if certain per share
stock price targets for our common stock are reached prior to January 12, 2003.
In conjunction with the acquisition, we also announced that we will soon be
seeking shareholder approval to change our name to W3 Inc., and that two members
of the former W3Commerce board of directors have become members of our board of
directors.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
---------------------------------
a) Financial statements of businesses acquired
-------------------------------------------
Not applicable.
b) Pro forma financial information
-------------------------------
Not applicable.
c) Exhibits
--------
99.1 Press release dated January 13, 2000 entitled "Synbiotics
Corporation Acquires Its Internet Marketing Partner,
Announces Strategic Changes, Plans to Rename."
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
SYNBIOTICS CORPORATION
Date: February 4, 2000 /s/ Michael K. Green
-------------------------------------
Michael K. Green
Senior Vice President - Finance
and Chief Financial Officer
-1-
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.
EXHIBITS
TO
FORM 8-K
UNDER
SECURITIES EXCHANGE ACT OF 1934
SYNBIOTICS CORPORATION
EXHIBIT INDEX
Exhibit No. Exhibit
- ----------- -------
99.1 Press release dated January 13, 2000 entitled "Synbiotics
Corporation Acquires Its Internet Marketing Partner, Announces
Strategic Changes, Plans to Rename."